Results 241 to 250 of about 113,609 (263)

Beyond CD19

Advances in Oncology
Erin E. Doherty, Helen E. Heslop
openaire   +1 more source

Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis

Cell
Ling Ying Ye, Le-Hang Guo, Hongjuan Lu
exaly  

CD19 antibodies and their uses

2012
RAO-NAIK CHETANA, KING DAVID JOHN, LIU JIE, HUANG HAICHUN, PASSMORE DAVID B, BELL ALASDAIR FRASER, CARDARELLI JOSEPHINE M, PAN CHIN, THI DO TO UYEN, CHEN SHARLINE, TANAMACHI DAWN M   +10 more
openaire   +2 more sources

CD19 Deficiency

2012
openaire   +1 more source

ANTI-HUMAN CD19 ANTIBODIES

2021
ALLAN BARRETT, BOYLES JEFFREY STREETMAN, BUDELSKY ALISON LEE SIM, RUBTSOVA KIRA VLADIMIROVNA, ZHANG GUIFENG, NA SONGQING   +5 more
openaire   +2 more sources

CD19 Molecule

2018
openaire   +1 more source

CD19 (16p11.2)

2008
openaire   +1 more source

Elimination of CD19-positive lymphoid malignancies by CD19-car expressing NK cells

2020
KLINGEMANN HANS G, BOISSEL LAURENT H, SOON-SHIONG PATRICK   +2 more
openaire   +4 more sources

Optimized antibodies that target CD19

2008
BERNETT MATTHEW J, CHU SEUNG YUP, DESJARLAIS JOHN R, KARKI SHER BAHADUR, LAZAR GREGORY ALAN, PONG ERIK WEIKING, RICHARDS JOHN O, ZHUKOVSKY EUGENE ALEXANDER   +7 more
openaire   +12 more sources

An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis

Cell
Le-Hang Guo
exaly